Biotricity, Inc. Common Stock
BTCY
BTCY was delisted on the 2nd of August, 2024.
32 hedge funds and large institutions have $6.27M invested in Biotricity, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
79% more call options, than puts
Call options by funds: $113K | Put options by funds: $63K
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
10% more funds holding
Funds holding: 29 → 32 (+3)
44% less capital invested
Capital invested by funds: $11.2M → $6.27M (-$4.96M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$334K |
| 2 |
CIM
Caldwell Investment Management
Toronto,
Ontario, Canada
|
+$320K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$169K |
| 4 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
+$97.7K |
| 5 |
VF
Virtu Financial
New York
|
+$63.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$1.15M |
| 2 |
KWM
Kingsview Wealth Management
Grants Pass,
Oregon
|
-$433K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$79.3K |
| 4 |
CMA
Cedar Mountain Advisors
Lake Oswego,
Oregon
|
-$60K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$19.9K |
BTCY Hedge Fund Activity: Q1 2022 in Review
32 of the 6,253 institutional investors tracked by Wall St. Rank reported a position in Biotricity, Inc. Common Stock (BTCY) for Q1 2022, worth a combined $6.27M — down 44% from $11.2M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new BTCY positions and 5 closed out — a net gain of 3 holders — while 7 added to existing stakes and 2 trimmed.
The largest buyer was State Street, adding an estimated $334K. The largest seller was EAM Investors, exiting entirely with an estimated $1.15M sold.
- 32 institutional investors held Biotricity, Inc. Common Stock (BTCY) as of Q1 2022, up from 29 in Q4 2021.
- Funds reported $6.27M of Biotricity, Inc. Common Stock stock for Q1 2022, down 44% quarter-over-quarter.
- 8 funds opened new Biotricity, Inc. Common Stock positions in Q1 2022 and 5 closed out, a net change of +3 holders.
- The largest Biotricity, Inc. Common Stock buyer in Q1 2022 was State Street, an estimated $334K added.
- The largest Biotricity, Inc. Common Stock seller in Q1 2022 was EAM Investors, an estimated $1.15M sold.
Based on aggregated 13F filings for Q1 2022.